1. The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
- Author
-
Inmaculada Moreno Alia, Kitty J. Jager, Runolfur Palsson, Evgueniy Vazelov, Harijs Cernevskis, Faical Jarraya, Patrice M. Ambühl, Viera Spustova, Fernando Macário, Jean Marin des Grottes, Raquel Fernández González, Ziad A. Massy, Angel L.M. de Francisco, Mykola Kolesnyk, Anneke Kramer, Frantisek Lopot, Bolesław Rutkowski, Alberto Martínez Castelao, Eliezer Golan, Felipe Arribas Monzón, Mai Ots-Rosenberg, Kyriakos Ioannou, Manuel I. Aparicio Madre, Carmen Santiuste de Pablos, Fergus Caskey, Liliana Garneata, Marina Ratkovic, Mathilde Lassalle, Reinhard Kramar, Maria Pippias, Maria de los Ángeles Garcia Bazaga, Encarnación Bouzas Caamaño, Vianda S. Stel, Visnja Lezaic, Marlies Noordzij, Nikolaos Afentakis, Marc H Hemmelder, Manuel Ferrer-Alamar, Nino Kantaria, Edita Ziginskiene, Ivan Bubić, Maria Fernanda Slon Roblero, James G. Heaf, Koenraad J.F. Stas, Ramón Alonso de la Torre, Maria Stendahl, Olivera Stojceva-Taneva, Alma Idrizi, Anders Åsberg, Patrik Finne, Wendy Metcalfe, Nurhan Seyahi, Maurizio Nordio, Halima Resić, Pablo Castro de la Nuez, Marjolein Bonthuis, Ángela Magaz, Eduardo Martín Escobar, APH - Quality of Care, APH - Aging & Later Life, Medical Informatics, Amsterdam Gastroenterology Endocrinology Metabolism, APH - Methodology, APH - Global Health, ACS - Pulmonary hypertension & thrombosis, Faculty of Medicine, Nefrologian yksikkö, Clinicum, Department of Medicine, and University of Helsinki
- Subjects
medicine.medical_specialty ,Pediatrics ,Epidemiology ,medicine.medical_treatment ,Population ,030232 urology & nephrology ,kidney transplantation ,030204 cardiovascular system & hematology ,urologic and male genital diseases ,survival analysis ,Kidney transplantation ,REPLACEMENT THERAPY ,03 medical and health sciences ,Autres spécialisations médicales et paramédicales ,0302 clinical medicine ,CKD ,medicine ,Renal replacement therapy ,ESRD ,education ,BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine ,Dialysis ,Survival analysis ,BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina ,Transplantation ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,3126 Surgery, anesthesiology, intensive care, radiology ,medicine.disease ,Transplantation d'organes ,female genital diseases and pregnancy complications ,3. Good health ,Nephrology ,3121 General medicine, internal medicine and other clinical medicine ,dialysis, epidemiology, ESRD, kidney transplantation, survival analysis ,dialysis ,epidemiology ,Hemodialysis ,business - Abstract
Background: This article summarizes the European Renal Association - European Dialysis and Transplant Association Registry's 2014 annual report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2014 within 35 countries. Methods: In 2016, the ERA-EDTA Registry received data on patients who in 2014 where undergoing RRT for ESRD, from 51 national or regional renal registries. Thirty-two registries provided individual patient level data and 19 provided aggregated patient level data. The incidence, prevalence and survival probabilities of these patients were determined. Results: In 2014, 70 953 individuals commenced RRT for ESRD, equating to an overall unadjusted incidence rate of 133 per million population (pmp). The incidence ranged by 10-fold; from 23 pmp in the Ukraine to 237 pmp in Portugal. Of the patients commencing RRT, almost two-thirds were men, over half were aged ≥65 years and a quarter had diabetes mellitus as their primary renal diagnosis. By day 91 of commencing RRT, 81% of patients were receiving haemodialysis. On 31 December 2014, 490 743 individuals were receiving RRT for ESRD, equating to an unadjusted prevalence of 924 pmp. This ranged throughout Europe by more than 10-fold, from 157 pmp in the Ukraine to 1794 pmp in Portugal. In 2014, 19 406 kidney transplantations were performed, equating to an overall unadjusted transplant rate of 36 pmp. Again this varied considerably throughout Europe. For patients commencing RRT during 2005-09, the 5-year-adjusted patient survival probabilities on all RRT modalities was 63.3% (95% confidence interval 63.0-63.6). The expected remaining lifetime of a 20- to 24-year-old patient with ESRD receiving dialysis or living with a kidney transplant was 21.9 and 44.0 years, respectively. This was substantially lower than the 61.8 years of expected remaining lifetime of a 20-year-old patient without ESRD., 0, SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2017